Aktienanalyse zu GP-Act III Acquisition Corp (GPAT)

KI-Analyse of GP-Act III Acquisition Corp (GPAT)

Halten

GP-Act III Acquisition Corp. is currently priced at 11.10, which is close to its 52-week high of 12.00, indicating limited upside potential. The RSI is at 65.189, suggesting that the stock is nearing overbought territory. Additionally, the forward P/E ratio is 0, which indicates uncertainty about future earnings. The main risk is the significant drop in net income to common stockholders in Q2 2026, which fell to 290,121 from 3,304,297 in Q4 2024, highlighting potential operational issues.

Bewertungskennzahlen

Das aktuelle erwartete KGV von GP-Act III Acquisition Corp (GPAT) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von 0.00.

Erwartetes KGV

Stark unterbewertet

5J-Durchschnitt P/E

0.00

Aktuelles P/E

0.00

Überbewertet

0.00

Unterbewertet

0.00

Erwartetes EV/EBITDA

Stark unterbewertet

5J-Durchschnitt EV/EBITDA

0.00

Aktuelles EV/EBITDA

0.00

Überbewertet

0.00

Unterbewertet

0.00

Erwartetes KUV

Fair bewertet

5J-Durchschnitt P/S

0.03

Aktuelles P/S

0.00

Überbewertet

0.62

Unterbewertet

-0.56

Alphio-AI-Kursszenarien für GPAT

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%GPAT

$10.98

Szenariopreis

B

Basis

Basis · 50%GPAT

$9.46

Szenariopreis

B

Bärisch

Bärisch · 25%GPAT

$8.29

Szenariopreis

Whales, die GPAT halten

P

Polar Asset Management Partners Inc.

+ HältGPAT

-2.91%

3-Monats-Rendite

GPAT FAQ – beantwortet von Alphio AI

GP-Act III Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It has neither engaged in any operations nor generated any revenues. It operates in the Financials sector.

GP-Act III Acquisition Corp. is currently priced at 11.10, which is close to its 52-week high of 12.00, indicating limited upside potential. The RSI is at 65.189, suggesting that the stock is nearing overbought territory. Additionally, the forward P/E ratio is 0, which indicates uncertainty about future earnings. The main risk is the significant drop in net income to common stockholders in Q2 2026, which fell to 290,121 from 3,304,297 in Q4 2024, highlighting potential operational issues.